Changes

Line 52: Line 52:  
|-
 
|-
 
|'''Laboratory Findings'''
 
|'''Laboratory Findings'''
|Noncontributory  
+
|Noncontributory
 
|}
 
|}
   Line 100: Line 100:  
|Positive (universal) - Cellular location of ALK staining varies depending on ALK translocation partner. In the most common t(2;5), most cases show both cytoplasmic and nuclear||ALK
 
|Positive (universal) - Cellular location of ALK staining varies depending on ALK translocation partner. In the most common t(2;5), most cases show both cytoplasmic and nuclear||ALK
 
|-
 
|-
|Positive (subset) ||EMA
+
|Positive (subset)||EMA
 
|-
 
|-
 
|Negative - >75% of cases are CD3-negative||CD3
 
|Negative - >75% of cases are CD3-negative||CD3
Line 122: Line 122:  
|Granzyme B
 
|Granzyme B
 
|-
 
|-
|Positive  
+
|Positive
 
|Perforin
 
|Perforin
 
|-
 
|-
|Variably positive  
+
|Variably positive
 
|CD45
 
|CD45
 
|-
 
|-
Line 164: Line 164:  
|-
 
|-
 
|t(2;5)(p23;q35)||3' ''ALK'' / 5' ''NPM1''<ref name=":20" />||''NPM1::ALK'' fusion protein||84%<ref name=":0" />
 
|t(2;5)(p23;q35)||3' ''ALK'' / 5' ''NPM1''<ref name=":20" />||''NPM1::ALK'' fusion protein||84%<ref name=":0" />
|No  
+
|No
 
|No
 
|No
 
|Yes
 
|Yes
Line 372: Line 372:  
|2q
 
|2q
 
|Gain
 
|Gain
|EXAMPLE
+
|Chr 2:29,192,774-29,921,586
 
  −
chr7:1- 159,335,973 [hg38]
   
|EXAMPLE
 
|EXAMPLE
    
chr7
 
chr7
|Yes
+
|No
 
|Yes
 
|Yes
 
|No
 
|No